Bridgeway Capital Management, LLC Chimerix Inc Transaction History

Bridgeway Capital Management, LLC

$4.76 Billion
Q1 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Chimerix Inc stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 1,081,124 shares of CMRX stock, worth $951,389. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,081,124

Previous 1,031,524 4.81%

Holding current value

$951,389

Previous $990,000 15.66%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.91 - $1.26 $45,136 - $62,496	49,600 Added 4.81%	1,081,124 $1.15 Million
Q4 2023 Feb 14, 2024	BUY	$0.9 - $1.06 $72,000 - $84,800	80,000 Added 8.41%	1,031,524 $990,000
Q3 2023 Nov 14, 2023	BUY	$0.94 - $1.23 $504,896 - $660,662	537,124 Added 129.61%	951,524 $913,000
Q2 2023 Aug 14, 2023	BUY	$1.1 - $1.54 $212,740 - $297,836	193,400 Added 87.51%	414,400 $501,000
Q1 2023 May 15, 2023	BUY	$1.19 - $2.09 $262,990 - $461,889	221,000 New	221,000 $278,000

Q4 2021 Feb 14, 2022	SELL	$5.23 - $7.18 $201,878 - $277,148	-38,600 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$7.54 - $9.79 $32,422 - $42,096	-4,300 Reduced 10.02%	38,600 $309,000
Q1 2021 May 17, 2021	SELL	$4.76 - $11.25 $998,648 - $2.36 Million	-209,800 Reduced 83.02%	42,900 $414,000
Q4 2020 Feb 16, 2021	BUY	$2.43 - $5.42 $121,500 - $271,000	50,000 Added 24.67%	252,700 $1.22 Million
Q3 2020 Nov 16, 2020	SELL	$2.3 - $3.72 $9,890 - $15,996	-4,300 Reduced 2.08%	202,700 $505,000
Q2 2020 Aug 14, 2020	SELL	$1.33 - $3.63 $33,250 - $90,750	-25,000 Reduced 10.78%	207,000 $642,000
Q1 2020 May 15, 2020	SELL	$1.27 - $2.33 $101,600 - $186,400	-80,000 Reduced 25.64%	232,000 $334,000
Q4 2019 Feb 14, 2020	BUY	$1.3 - $2.72 $114,530 - $239,632	88,100 Added 39.35%	312,000 $633,000
Q3 2019 Nov 14, 2019	BUY	$1.93 - $4.21 $74,884 - $163,348	38,800 Added 20.96%	223,900 $526,000
Q2 2019 Aug 14, 2019	SELL	$2.05 - $4.32 $192,904 - $406,512	-94,100 Reduced 33.7%	185,100 $800,000
Q1 2019 May 15, 2019	BUY	$1.79 - $3.12 $179,000 - $312,000	100,000 Added 55.8%	279,200 $586,000
Q4 2018 Feb 14, 2019	SELL	$2.24 - $3.9 $134,400 - $234,000	-60,000 Reduced 25.08%	179,200 $461,000
Q4 2017 Feb 14, 2018	BUY	$4.32 - $5.52 $388,368 - $496,247	89,900 Added 60.21%	239,200 $1.11 Million
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.25 $649,455 - $783,825	149,300	149,300 $784,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

29.6M

Call Options Held

18.9K

Put Options Held

40.9K

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $77.1M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Chimerix Inc Transaction History